122 related articles for article (PubMed ID: 4065179)
1. Antagonism of aminoglutethimide and danazol in the suppression of serum free oestradiol in breast cancer patients.
Dowsett M; Murray RM; Pitt P; Jeffcoate SL
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1063-8. PubMed ID: 4065179
[TBL] [Abstract][Full Text] [Related]
2. Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancer.
Dowsett M; Murray RM; Pitt P; Jeffcoate SL
Ann Clin Biochem; 1986 May; 23 ( Pt 3)():277-84. PubMed ID: 3789634
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
Coombes RC; Powles TJ; Rees LH; Ratcliffe WA; Nash AG; Henk M; Ford HT; Gazet JC; Neville AM
Br J Cancer; 1982 Jul; 46(1):30-4. PubMed ID: 7104195
[TBL] [Abstract][Full Text] [Related]
4. Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.
Alexieva-Figusch J; de Jong FH; Lamberts WJ; van Gilse HA; Klign JG
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1349-56. PubMed ID: 2960533
[TBL] [Abstract][Full Text] [Related]
5. Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Carlström K; Pousette A; Rannevik G; Sköldefors H; Theve NO; Wilking N
Breast Cancer Res Treat; 1986; 7 Suppl():S107-9. PubMed ID: 2943337
[No Abstract] [Full Text] [Related]
6. Endocrine effects of danazol in the treatment of endometriosis.
Bevan JR; Dowsett M; Jeffcoate SL
Br J Obstet Gynaecol; 1984 Feb; 91(2):160-6. PubMed ID: 6538094
[TBL] [Abstract][Full Text] [Related]
7. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
Dowsett M; Harris AL; Stuart-Harris R; Hill M; Cantwell BM; Smith IE; Jeffcoate SL
Br J Cancer; 1985 Oct; 52(4):525-9. PubMed ID: 2933050
[TBL] [Abstract][Full Text] [Related]
9. Free testosterone levels during danazol therapy.
Nilsson B; Södergård R; Damber MG; Damber JE; von Schoultz B
Fertil Steril; 1983 Apr; 39(4):505-9. PubMed ID: 6682051
[TBL] [Abstract][Full Text] [Related]
10. Aminoglutethimide dose and hormone suppression in advanced breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; Smith IE
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):493-8. PubMed ID: 6222901
[TBL] [Abstract][Full Text] [Related]
11. Role of aminoglutethimide in male breast cancer.
Harris AL; Dowsett M; Stuart-Harris R; Smith IE
Br J Cancer; 1986 Oct; 54(4):657-60. PubMed ID: 3778807
[TBL] [Abstract][Full Text] [Related]
12. Hormonal effects of danazol and medical oophorectomy in endometriosis.
Meldrum DR; Pardridge WM; Karow WG; Rivier J; Vale W; Judd HL
Obstet Gynecol; 1983 Oct; 62(4):480-5. PubMed ID: 6350956
[TBL] [Abstract][Full Text] [Related]
13. Hormone binding globulin levels in patients with hereditary angiooedema during treatment with Danazol.
Schwarz S; Tappeiner G; Hintner H
Clin Endocrinol (Oxf); 1981 Jun; 14(6):563-70. PubMed ID: 6794961
[TBL] [Abstract][Full Text] [Related]
14. Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.
Stuart-Harris R; Dowsett M; D'Souza A; Donaldson A; Harris AL; Jeffcoate SL; Smith IE
Clin Endocrinol (Oxf); 1985 Feb; 22(2):219-26. PubMed ID: 2985301
[TBL] [Abstract][Full Text] [Related]
15. Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
Harris AL; Dowsett M; Smith IE; Jeffcoate S
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):463-9. PubMed ID: 6233150
[TBL] [Abstract][Full Text] [Related]
16. Danazol treatment for advanced breast cancer.
Coombes RC; Perez D; Gazet JC; Ford HT; Powles TJ
Cancer Chemother Pharmacol; 1983; 10(3):194-5. PubMed ID: 6345017
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
MacNeill FA; Jacobs S; Lønning PE; Powles TJ; Dowsett M
Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum prolactin levels in advanced breast cancer.
Dowsett M; McGarrick GE; Harris AL; Coombes RC; Smith IE; Jeffcoate SL
Br J Cancer; 1983 Jun; 47(6):763-9. PubMed ID: 6860546
[TBL] [Abstract][Full Text] [Related]
19. [Changes in % free testosterone and sex-hormone binding globulin during danazol administration].
Asai M; Ohsawa M; Ichikawa Y; Wu MC; Masahashi T; Narita O; Matsui N; Kashiwamata S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1001-6. PubMed ID: 4040541
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
Dowsett M; Harris AL; Smith IE; Jeffcoate SL
Br J Cancer; 1984 Sep; 50(3):357-61. PubMed ID: 6540595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
